TGFB1 and benign prostatic hyperplasia: The results showed that miR-1202 overexpression and inhibition were successfully achieved, and TGF-β treatment considerably promoted miR-1202 upregulation in both BPH-1 (Figure 2A) and RWPE-1 (Supplementary Figure S1A) cells.